My Fund

Loading your portfolio…

Checking your account and saved picks.

Choose a startup

Explore all 1120 companies in this selection. Research each company before making your pick.

Includes historical VC holdings. A listing does not confirm current ownership or startup stage.

VC tracking →

Showing 1–18 of 18 startups

Science

Collecting history

Company website description

Science Corporation is a clinical-stage medical technology company.

Khosla Ventures
science.xyz ↗
Research Science

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Science Corporation is a clinical-stage medical technology company.

Visit science.xyz ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

1 AU

Limited coverage

Company website description

1AU Technologies is assembling a world-class team of experts in materials science, optics, and laser physics to pioneer next-generation photonic systems.

Bessemer Venture Partners
1autechnologies.com ↗
Research 1 AU

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Homepage checked. Exit news coverage is not established.Homepage checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

1AU Technologies is assembling a world-class team of experts in materials science, optics, and laser physics to pioneer next-generation photonic systems.

Visit 1autechnologies.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

3T Biosciences

Limited coverage

Company website description

We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the treatment of solid…

CRV
3tbiosciences.com ↗
Research 3T Biosciences

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Homepage checked. Exit news coverage is not established.Homepage checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the treatment of solid…

Visit 3tbiosciences.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Apeel Sciences

Collecting history

Company website description

How does Apeel's plant-based protection make produce last longer? By mimicking plants' cuticle layer, Apeel creates a little extra "peel". Learn more!

Andreessen Horowitz
apeel.com ↗
Research Apeel Sciences

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

How does Apeel's plant-based protection make produce last longer? By mimicking plants' cuticle layer, Apeel creates a little extra "peel". Learn more!

Visit apeel.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

BigHat Biosciences

Limited coverage

Product details not available yet.

Andreessen Horowitz
bighatbio.com ↗
Research BigHat Biosciences

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

Product details not available yet.

Visit bighatbio.com ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Bold

Source check held

Company website description

Bold is your home for personalized, science-backed workouts shown to reduce fall risk. Assess your strength, mobility, and balance with a free 1-minute test.

Andreessen HorowitzKhosla Ventures
agebold.com ↗
Research Bold

Tracking coverage

A source check is on hold. Previous evidence is retained.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Source check held
Latest source check was held; no new exit evidence was confirmed.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Bold is your home for personalized, science-backed workouts shown to reduce fall risk. Assess your strength, mobility, and balance with a free 1-minute test.

Visit agebold.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Cartography Biosciences

Limited coverage

Company website description

Mapping Biology to Precise Medicines The best therapeutics are built around the best targets. By analyzing massive datasets from individual human cells, Cartography is identifying…

Andreessen Horowitz
cartography.bio ↗
Research Cartography Biosciences

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Mapping Biology to Precise Medicines The best therapeutics are built around the best targets. By analyzing massive datasets from individual human cells, Cartography is identifying…

Visit cartography.bio ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Click Therapeutics, Inc.

Collecting history

Other Health Care

On its website, the company describes its work as “Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with the power of…”.

No tracked VC backing recorded
clicktherapeutics.com ↗
Research Click Therapeutics, Inc.

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with the power of…”.

Visit clicktherapeutics.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $49,999,999 · Offering amount as filed: $49,999,999

    SEC source checked 29 Oct 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Excelsior Sciences

Limited coverage

Company website description

Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing.

Khosla Ventures
excelsiorsci.com ↗
Research Excelsior Sciences

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing.

Visit excelsiorsci.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Gate Bio

Limited coverage

Company website description

Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at…

Andreessen Horowitz
gatebio.com ↗
Research Gate Bio

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at…

Visit gatebio.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Hilbert

Limited coverage

Company website description

Hilbert is a scalable, data science-first growth infra that gives B2C teams predictive clarity into user behavior, revenue drivers, and the actions that drive sustainable…

Andreessen Horowitz
hilberts.ai ↗
Research Hilbert

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Hilbert is a scalable, data science-first growth infra that gives B2C teams predictive clarity into user behavior, revenue drivers, and the actions that drive sustainable…

Visit hilberts.ai ↗Product description source ↗

Product source checked 31 Oct 2026

Published location

Wilmington, DE, US

Location source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

KiwiCo

Collecting history

Consumer

Company website description

KiwiCo delivers science and art projects for kids of all ages

FelicisFirst Round Capital
kiwico.com ↗
Research KiwiCo

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

KiwiCo delivers science and art projects for kids of all ages

Visit kiwico.com ↗Product description source ↗

Product source checked 31 Oct 2026

Source category

Consumer

Category source ↗

Checked

Published location

SF Bay Area

Location source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Komodo Health

Collecting history

Company website description

Komodo Health combines the most complete real-world data foundation, validated healthcare AI, and purpose-built Life Sciences workflows, so your teams get verified answers fast enough…

Felicis
komodohealth.com ↗
Research Komodo Health

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Komodo Health combines the most complete real-world data foundation, validated healthcare AI, and purpose-built Life Sciences workflows, so your teams get verified answers fast enough…

Visit komodohealth.com ↗Product description source ↗

Product source checked 31 Oct 2026

Published location

San Francisco, CA, US

Location source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Moonwalk Biosciences

Limited coverage

Company website description

By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies…

Khosla Ventures
moonwalk.bio ↗
Research Moonwalk Biosciences

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies…

Visit moonwalk.bio ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Rubedo

Limited coverage

Company website description

Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.

Khosla Ventures
rubedolife.com ↗
Research Rubedo

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.

Visit rubedolife.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Signal Sciences

Limited coverage

Product details not available yet.

CRV
signalsciences.com ↗
Research Signal Sciences

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

Product details not available yet.

Visit signalsciences.com ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Udacity

Collecting history

Company website description

Learn online and advance your career with courses in programming, data science, artificial intelligence, digital marketing, and more. Gain in-demand technical skills. Join today!

CRV
udacity.com ↗
Research Udacity

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Learn online and advance your career with courses in programming, data science, artificial intelligence, digital marketing, and more. Gain in-demand technical skills. Join today!

Visit udacity.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Warp Sciences

Limited coverage

Company website description

Warp is the AI-driven U.S. chemistry CRO that turns AI-designed molecules into compounds drug discovery teams can test, in labs built for automation.

IVP
warp.xyz ↗
Research Warp Sciences

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Warp is the AI-driven U.S. chemistry CRO that turns AI-designed molecules into compounds drug discovery teams can test, in labs built for automation.

Visit warp.xyz ↗Product description source ↗

Product source checked 31 Oct 2026

Published location

South San Francisco, CA, US

Location source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗
How it works

Pick up to 50 companies. Your picks are private to your account.

A new US fundraising disclosure (Form D) earns 2 points. A first investment announced by a tracked VC earns 3. Milestones must occur and be observed after your pick.

Measured growth earns 1 point once: the same RiseFinder composite score rises between dated observations after your pick, using one formula version. Where available, a supported public source metric can also qualify. Lower ranks are better; rising counts are better. A completed, dated IPO or acquisition earns 10 points once.

The composite score measures relative public signals on a 0–100 scale. It is not a company valuation. Coverage varies; companies without qualifying history wait for evidence.

Initial imports, old discoveries, follow-ons from existing backers, amendments, undated events and same-day events earn no points.

Points track verified milestones after your pick. They do not represent investment returns.